JTX-2011
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for JTX-2011, covering 2021-09-09 to 2021-09-09. Get the full timeline:
Most recent: Clinical Trial Update: JTX-2011 Alone and in Combination With Anti-PD-1 or Anti-CTLA-4 in Subjects With Advanced and/or Refractory Solid Tumors [Phase 1, Phase 2]